Home › Ovarian Epithelial Carcinoma › Virginia › Norfolk
Ovarian Epithelial Carcinoma clinical trials in Norfolk, VA
3 studies for Ovarian Epithelial Carcinoma are looking for participants at sites in and around Norfolk (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
RecruitingPhase 2
- Virginia Oncology Associates- Norfolk (Brock) /ID# 275227, Norfolk
Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer
RecruitingPhase 3
- Research Site, Norfolk
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
RecruitingPhase 2
- SCRI - Virginia Oncology Associates, Norfolk
Ovarian Epithelial Carcinoma trials in other cities
- New York City, NY10 studies
- Boston, MA8 studies
- Durham, NC8 studies
- Cleveland, OH7 studies
- Houston, TX7 studies
- Baltimore, MD6 studies
- Chicago, IL6 studies
- Philadelphia, PA6 studies
- Salt Lake City, UT6 studies
- Edison, NJ5 studies
- Los Angeles, CA5 studies
- Minneapolis, MN5 studies
Other studies in Norfolk
- Breast Cancer17 studies
- Bladder Cancer8 studies
- Prostate Cancer8 studies
- Ovarian Cancer8 studies
- Cancer (all types)7 studies
- Cardiovascular Disease7 studies
- Abdominal Aortic Aneurysm7 studies
- Non-Small Cell Lung Cancer7 studies
- Spinal Muscular Atrophy6 studies
- Heart Failure6 studies
- Colorectal Cancer5 studies
- Obesity5 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.